(Reuters) - Pfizer Inc may sweeten its offer for Britain's AstraZeneca Plc to more than 63 billion pounds, or $106 billion, and raise the cash portion of the deal, to kickstart negotiations, Bloomberg reported on Thursday.
Citing people with knowledge of the matter, the report said a new bid may value ASTRAZENECA (AZN.LO)at more than 50 pounds per share and could come as early as next week. PFIZER (PFE.NY)disclosed earlier this week that it had twice approached AstraZeneca about a takeover, only to be rebuffed in both cases.
Pfizer officials could not immediately be reached for comment.
(Reporting by Michele Gershberg)
Relacionados
- Pfizer y Astrazeneca: los accionistas ganan y el fisco de EEUU pierde
- AstraZeneca rechaza otra oferta de 72.000 millones de Pfizer
- (Amp) AstraZeneca responde a Pfizer que confía en generar valor para sus accionistas como firma independiente
- Economía.- (Amp) AstraZeneca responde a Pfizer que confía en generar valor para sus accionistas como firma independiente
- Pfizer confirma que está interesada en hacerse con el control de AstraZeneca
